clotrimazole has been researched along with Fanconi Anemia in 2 studies
Fanconi Anemia: Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghanshani, S | 1 |
Coleman, M | 1 |
Gustavsson, P | 1 |
Wu, AC | 1 |
Gargus, JJ | 1 |
Gutman, GA | 1 |
Dahl, N | 1 |
Mohrenweiser, H | 1 |
Chandy, KG | 1 |
Voter, AF | 1 |
Manthei, KA | 1 |
Keck, JL | 1 |
2 other studies available for clotrimazole and Fanconi Anemia
Article | Year |
---|---|
Human calcium-activated potassium channel gene KCNN4 maps to chromosome 19q13.2 in the region deleted in diamond-blackfan anemia.
Topics: Chromosome Mapping; Chromosomes, Human, Pair 19; Fanconi Anemia; Humans; Intermediate-Conductance Ca | 1998 |
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
Topics: Antineoplastic Agents; DNA Damage; DNA Helicases; DNA Repair; Drug Screening Assays, Antitumor; Fanc | 2016 |